Transglutaminase 2 in the enterocytes is coeliac specific and gluten dependent

被引:16
作者
Biagi, F.
Campanella, J.
Laforenza, U.
Gastaldi, G.
Tritto, S.
Grazioli, M.
Villanacci, V.
Corazza, G. R.
机构
[1] Univ Pavia, Dept Internal Med 1, IRCCS, Policlin San Matteo, I-27100 Pavia, Italy
[2] Univ Pavia, Sect Human Physiol, Dept Expt Med 1, I-27100 Pavia, Italy
[3] Univ Brescia, Spedali Civili, Dept Pathol 2, I-25125 Brescia, Italy
关键词
coeliac disease; enterocytes; gliadin; tissue transglutaminase;
D O I
10.1016/j.dld.2006.05.021
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background. Tissue transglutaminase, the coeliac autoantigen, was shown to localise in the enterocytes of coeliac patients and controls. It was speculated that surface tissue transglutaminase has a role in the pathogenesis of coeliac disease. Aims. To study localisation of tissue transglutaminase in different stages of coeliac disease and other enteropathies with and without villous flattening. Methods. Imunofluorescent and immunoblotting assays were used. Duodenal cryostat sections from 23 coeliac patients (10 untreated, 8 treated, 5 potential) and 18 controls (2 autoimmune enteropathy and 16 normal duodenal mucosa) were incubated with an anti-tissue transglutaminase monoclonal antibody. Slides were blindly examined. Results. The immunofluorescent assay showed that monoclonal antibody localised in the subepithelial layer, in the lamina propria, and in the pericryptal connective tissue of all samples. It also bound to surface enterocytes in 8/10 untreated, 1/8 treated, and 3/5 potential coeliac patients. None of the controls showed an epithelial distribution of tissue transglutaminase. Immunoblotting experiments performed in enterocytes freshly isolated from duodenal biopsy confirmed these findings. Conclusion. Epithelial distribution of tissue transglutaminase is specific for coeliac disease rather than due to a non-specific mucosal inflammation. Analysis of different stages of coeliac disease suggests that the epithelial distribution of tissue transglutaminase is gluten dependent. (c) 2006 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:652 / 658
页数:7
相关论文
共 36 条
[1]   In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope [J].
Anderson, RP ;
Degano, P ;
Godkin, AJ ;
Jewell, DP ;
Hill, AVS .
NATURE MEDICINE, 2000, 6 (03) :337-342
[2]   The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase [J].
Arentz-Hansen, H ;
Körner, R ;
Molberg, O ;
Quarsten, H ;
Vader, W ;
Kooy, YMC ;
Lundin, KEA ;
Koning, F ;
Roepstorff, P ;
Sollid, LM ;
McAdam, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :603-612
[3]   INTESTINAL ANTIBODY PATTERN OF CELIAC-DISEASE - OCCURRENCE IN PATIENTS WITH NORMAL JEJUNAL BIOPSY HISTOLOGY [J].
ARRANZ, E ;
FERGUSON, A .
GASTROENTEROLOGY, 1993, 104 (05) :1263-1272
[4]   CRITERIA OF VIABILITY OF ISOLATED LIVER-CELLS [J].
BAUR, H ;
KASPEREK, S ;
PFAFF, E .
HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1975, 356 (06) :827-838
[5]   Is gliadin mispresented to the immune system in coeliac disease? A hypothesis [J].
Biagi, F ;
Zimmer, KP ;
Thomas, PD ;
Ellis, HJ ;
Ciclitira, PJ .
QJM-MONTHLY JOURNAL OF THE ASSOCIATION OF PHYSICIANS, 1999, 92 (02) :119-122
[6]  
Biagi F, 2003, DIGESTION, V68, P89
[7]   Clinical features of coeliac disease [J].
Biagi, F ;
Corazza, GR .
DIGESTIVE AND LIVER DISEASE, 2002, 34 (03) :225-228
[8]  
Brusco G, 1999, CLIN EXP IMMUNOL, V118, P371
[9]   Gliadin and tissue transglutaminase complexes in normal and coeliac duodenal mucosa [J].
Ciccocioppo, R ;
Di Sabatino, A ;
Ara, C ;
Biagi, F ;
Perilli, M ;
Amicosante, G ;
Cifone, MG ;
Corazza, GR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 134 (03) :516-524
[10]   Mechanisms of villous atrophy in autoimmune enteropathy and coeliac disease [J].
Ciccocioppo, R ;
D'Alò, S ;
Di Sabatino, A ;
Parroni, R ;
Rossi, M ;
Doglioni, C ;
Cifone, MG ;
Corazza, GR .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2002, 128 (01) :88-93